(0779–0806) Infection-related Rheumatic Disease Poster

Sunday, November 13, 2022

9:00 AM – 10:30 AM Eastern Time

Location: Virtual Poster Hall

All of the relevant financial relationships listed for faculty have been mitigated.

Poster abstract session.

Presentations:

9:00 AM – 10:30 AM Eastern Time

Early Experience of Breakthrough COVID-19 Infections in Patients Who Received Pre-exposure Prophylaxis with Tixagevimab/cilgavimab
Abstract Poster Presenter: Cassandra Calabrese, DO – Cleveland Clinic Foundation
9:00 AM – 10:30 AM Eastern Time

B-cell Reconstitution Is Associated with COVID-19 Booster Vaccine Responsiveness in Previously Seronegative Rituximab Treated Rheumatic Disease Patients
Abstract Poster Presenter: Kaitlin Schultz, BA – Hospital for Special Surgery
9:00 AM – 10:30 AM Eastern Time

Rituximab Treated Patients with Hypogammaglobulinemia Are Less Likely to Seroconvert Following SARS-CoV-2 Vaccine Supplemental Dose
Abstract Poster Presenter: Emily Rose, MD – Beth Israel Deaconess Medical Center
9:00 AM – 10:30 AM Eastern Time

Low Circulating B Cells Correlate with Unresponsiveness to COVID-19 Vaccination Among Patients Treated with Rituximab
Abstract Poster Presenter: Christopher Halbur, BS – University of Iowa
9:00 AM – 10:30 AM Eastern Time

Breakthrough SARS-CoV-2 Infections and Predicting Severe Outcomes During Rituximab Therapy in Autoimmune Rheumatic Diseases
Abstract Poster Presenter: Md Yuzaiful Md Yusof, PhD, MBChB, MRCP – University of Leeds
9:00 AM – 10:30 AM Eastern Time

Breakthrough SARS-CoV-2 Infections in Immune Mediated Disease Patients Undergoing B Cell Depleting Therapy: A Retrospective Cohort Analysis
Abstract Poster Presenter: Cassandra Calabrese, DO – Cleveland Clinic Foundation
9:00 AM – 10:30 AM Eastern Time

Humoral Immune Responses Following Four SARS-CoV-2 Vaccine Doses or COVID-19 Infection in Patients with Immune-Mediated Inflammatory Diseases on Immunosuppressive Therapy: A Prospective Cohort Study
Abstract Poster Presenter: Hilde Ørbo, MD – Diakonhjemmet Hospital
9:00 AM – 10:30 AM Eastern Time

Humoral and T-cell Responses to SARS-CoV-2 Vaccination in Patients with Rheumatoid Arthritis
Abstract Poster Presenter: Carolina Isnardi, MD – UNISAR
9:00 AM – 10:30 AM Eastern Time

Relationship Between Humoral and Cellular Immune Responses in Persons with Rheumatoid Arthritis Following a Third Dose of COVID-19 Vaccine
Abstract Poster Presenter: Sara Tedeschi, MD, MPH – Brigham and Women's Hospital
9:00 AM – 10:30 AM Eastern Time

Development of Autoantibodies and Their Association with Flare-ups of Rheumatic Diseases in Adult Patients with Autoimmune Inflammatory Rheumatic Diseases (AIIRD) and the General Population Following BNT162b2 mRNA COVID-19 Vaccination - Results of 1-year Prospective Follow-up Study
Abstract Poster Presenter: Tal Gazitt, MD – Carmel Hospital
9:00 AM – 10:30 AM Eastern Time

The Persistence of Anti-Spike Antibodies Following Two SARS-CoV-2 Vaccine Doses in Patients with Immune-mediated Inflammatory Diseases on Immunosuppressive Therapy Compared to Healthy Controls: A Prospective Cohort Study
Abstract Poster Presenter: Ingrid Christensen, MD – Diakonhjemmet Hospital
9:00 AM – 10:30 AM Eastern Time

Sustainability of Immunogenicity of BNT162b2 Vaccine in Patients with Autoimmune Rheumatic Disease, a Retrospective Comparative Study
Abstract Poster Presenter: Omar Alsaed, MBBS, MRCP – Hamad Medical Corporation
9:00 AM – 10:30 AM Eastern Time

Immunogenicity and Safety of a Three-dose SARS-CoV-2 Vaccination Strategy in Patients with Immune-mediated Inflammatory Diseases on Immunosuppressive Therapy
Abstract Poster Presenter: Ingrid Jyssum, MD – Diakonhjemmet Hospital
9:00 AM – 10:30 AM Eastern Time

Post-mRNA Vaccine Flares in Autoimmune Inflammatory Rheumatic Diseases: Results from the COronavirus National Vaccine Registry for ImmuNe Diseases SINGapore (CONVIN-SING)
Abstract Poster Presenter: Manjari Lahiri, MD, MBBS, MRCP – National University Hospital
9:00 AM – 10:30 AM Eastern Time

Autonomic Nervous System Dysfunction Common Among Patients with Long COVID: An Exploratory Evaluation
Abstract Poster Presenter: Norman Gaylis, MD – Arthritis & Rheumatic Disease Specialties
9:00 AM – 10:30 AM Eastern Time

Impact of Vaccination on Post-acute Sequelae of SARS CoV-2 Infection in Patients with Rheumatic Diseases
Abstract Poster Presenter: Naomi Patel, MD – Massachusetts General Hospital
9:00 AM – 10:30 AM Eastern Time

Post-Acute COVID-19 Sequalae (PACS) with New-onset Rheumatological Complications
Abstract Poster Presenter: Manali Mukherjee, PhD – McMaster University
9:00 AM – 10:30 AM Eastern Time

SARS-CoV-2 Vaccine in Axial Spondyloarthritis and Psoriatic Arthritis: Does Sulfasalazine Counterbalance TNFI Impaired Immunogenicity?
Abstract Poster Presenter: Carla Goncalves Schahin Saad, MD, PhD – Faculdade de Medicina da Universidade de Sao Paulo
9:00 AM – 10:30 AM Eastern Time

Increased Duration of Mycophenolate Hold Improves Antibody Response to SARS-CoV-2 Vaccination in Patients with Rheumatic and Musculoskeletal Disease
Abstract Poster Presenter: Sarah Frey, BS – Johns Hopkins University School of Medicine
9:00 AM – 10:30 AM Eastern Time

Uncovering the Relationship Between COVID-19 Outcome Severity and Rheumatic Disease
Abstract Poster Presenter: Natalie Allcott, DO – Virginia Commonwealth University
9:00 AM – 10:30 AM Eastern Time

Serum Laboratory Parameters of Hemophagocytic Lymphohistiocytosis Syndrome in Patients with Autoimmune Rheumatic Diseases Infected with SARS-CoV-2: A Retrospective Comparative Study
Abstract Poster Presenter: Omar Alsaed, MBBS, MRCP – Hamad Medical Corporation
9:00 AM – 10:30 AM Eastern Time

Antibody Response to Shingrix Vaccination in Patients with Rheumatoid Arthritis, Seronegative Spondyloarthropathy and Systemic Lupus Erythematosus on Immunosuppressive Medications
Abstract Poster Presenter: Alina Kifayat, MD – Westchester Medical Center
9:00 AM – 10:30 AM Eastern Time

Impact of Diagnosis and Treatment of Tropheryma Whipplei Infection in Patients with Pre-existing Chronic Inflammatory Rheumatic Diseases: Data from the National Tw-IRD Registry
Abstract Poster Presenter: Damien CAILLET PORTILLO, MD – Toulouse University Hospital
9:00 AM – 10:30 AM Eastern Time

Is There Any Relationship Between Helicobacter Pylori and Rheumatoid Arthritis?
Abstract Poster Presenter: Hui Wu, PhD – 1. The Eighth Affiliated Hospital of Sun Yat-sen University
9:00 AM – 10:30 AM Eastern Time

Performance of Adenosine Deaminase Activity in Sinovial Fluid for the Early Diagnosis of Tuberculous Arthritis: A Meta Analysis
Abstract Poster Presenter: Juan Carlos Cortés-Quiroz, MD – LILLY
9:00 AM – 10:30 AM Eastern Time

Incidence and Risk Factors of Active Tuberculosis in Patients with Rheumatic Diseases Complicated with Tuberculosis Infection: A Multicenter Prospective Cohort Study
Abstract Poster Presenter: Yuchen Liu, MD – Peking Union Medical College Hospital
9:00 AM – 10:30 AM Eastern Time

WITHDRAWN
9:00 AM – 10:30 AM Eastern Time

Long-term Effectiveness of Sublingual Polybacterial Vaccines in Patients with Systemic Autoimmune Disease and Active Pharmacological Immunosuppression
Abstract Poster Presenter: Ines Perez Sancristobal, MD – Hospital Clinico San Carlos